High risk neuroblastomas showed low WNT5A-L expression more frequently than low risk tumors (55% -22 of 40- versus 21% -8 of 37-, P= 0.004), thus suggesting that WNT5A-L down-regulation correlates with high risk neuroblastoma. Here, WNT5A is linked to neuroblastoma.